COVID-19 infection in Crohn's disease under treatment with adalimumab

被引：41
作者：
Tursi, Antonio [1 ]
Angarano, Gioacchino [2 ]
Monno, Laura [2 ]
Saracino, Annalisa [2 ]
Signorile, Fabio [2 ]
Ricciardi, Aurelia [2 ]
Papa, Alfredo [3 ]
机构：
[1] Azienda Sanit Locale Barletta Andria Trani, Gastroenterol Serv, Andria, Puglia, Italy
[2] Univ Bari, Bari Univ Hosp, Div Infect Dis, Bari, Puglia, Italy
[3] Univ Cattolica Sacro Cuore, Fac Med & Surg, Div Internal Med & Gastroenterol, Complesso Integrato Columbus, Rome, Lazio, Italy
来源：
GUT | 2020年 / 69卷 / 07期
关键词：
crohn's disease; immune response;
D O I：
10.1136/gutjnl-2020-321240
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1364 / +
页数：2
相关论文
共 50 条
  • [21] Adalimumab therapy in Crohn's disease of the ileal pouch
    Li, Yue
    Lopez, Rocio
    Queener, Elaine
    Shen, Bo
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (12) : 2232 - 2239
  • [22] Conceptualizing socio-emotional disablism: a duoethnography of Crohn's disease and OCD during COVID-19
    Cole, Kristen L. L.
    Lawless, Brandi
    DISABILITY & SOCIETY, 2024, 39 (10) : 2528 - 2545
  • [23] Clinical effects of adalimumab treatment with concomitant azathioprine in Japanese Crohn's disease patients
    Kumi Ishida
    Takuya Inoue
    Kaori Fujiwara
    Taisuke Sakanaka
    Ken Narabayashi
    Sadaharu Nouda
    Toshihiko Okada
    Kazuki Kakimoto
    Takanori Kuramoto
    Ken Kawakami
    Yosuke Abe
    Toshihisa Takeuchi
    Mitsuyuki Murano
    Satoshi Tokioka
    Eiji Umegaki
    Kazuhide Higuchi
    World Journal of Gastroenterology, 2013, (17) : 2676 - 2682
  • [24] Clinical effects of adalimumab treatment with concomitant azathioprine in Japanese Crohn's disease patients
    Ishida, Kumi
    Inoue, Takuya
    Fujiwara, Kaori
    Sakanaka, Taisuke
    Narabayashi, Ken
    Nouda, Sadaharu
    Okada, Toshihiko
    Kakimoto, Kazuki
    Kuramoto, Takanori
    Kawakami, Ken
    Abe, Yosuke
    Takeuchi, Toshihisa
    Murano, Mitsuyuki
    Tokioka, Satoshi
    Umegaki, Eiji
    Higuchi, Kazuhide
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (17) : 2676 - 2682
  • [25] Maternal COVID-19 Disease and COVID-19 Immunization
    Sunder, Amala
    Varghese, Bessy
    Taha, Omer
    Keshta, Mohamed S.
    Bughamar, Ameena Khalid
    Mohamed, Enas Nadir Abelhamid
    Fadhulalla, Yusra Mirghani Aljailani
    Darwish, Basma
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [26] Treatment of Hepatitis C with Glecaprevir/Pibrentasvir in a Patient with Concurrent Stricturing Crohn's Disease on Adalimumab
    Hashim, Almoutaz
    WORLD FAMILY MEDICINE, 2021, 19 (02): : 143 - 145
  • [27] Crohn's Disease Associated Pyoderma Gangrenosum Treated with Adalimumab
    Kakagia, Despoina
    Efremidou, Eleni
    Lyratzopoulos, Nikolaos
    Mitrakas, Alexandros
    Pitiakoudis, Michael
    Kouklakis, George
    BALKAN MEDICAL JOURNAL, 2012, 29 (01) : 93 - 95
  • [28] Leukocytoclastic Vasculitis Associated with Adalimumab Therapy for Crohn's Disease
    Xu, Lankai Cathy
    Grandhe, Sirisha
    Marsano, Joseph G.
    CASE REPORTS IN GASTROENTEROLOGY, 2022, 17 (01) : 143 - 147
  • [29] Adalimumab treatment in Crohn's disease does not induce early changes in regulatory T cells
    Dige, Anders
    Hvas, Christian Lodberg
    Deleuran, Bent
    Kelsen, Jens
    Bendix-Struve, Mia
    Dahlerup, Jens Frederik
    Agnholt, Jorgen
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2011, 46 (10) : 1206 - 1214
  • [30] Effectiveness of infliximab after adalimumab failure in Crohn's disease
    María Chaparro
    Montserrat Andreu
    Manuel Barreiro-de Acosta
    Esther García-Planella
    Elena Ricart
    Eugeni Domènech
    María Esteve
    Olga Merino
    Pilar Nos
    Mireia Pealva
    Javier P Gisbert
    World Journal of Gastroenterology, 2012, (37) : 5219 - 5224
12345